Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity

Coverage, in order

1. 5d ago
   first NEJM indie study peer-reviewed

   Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity

   New England Journal of Medicine, Ahead of Print.

2. 3d ago
   
   Everyday Health mainstream study

   Retatrutide ‘Significantly’ Eases Knee Pain in People With Obesity, Studies Show

   Buzz surrounding the drug retatrutide continues to grow, as the medication shows dramatic results in clinical trials for type 2 diabetes , obesity , and other health conditions. Retatrutide is not yet approved by the U.S. Food and Drug Administration (FDA) for use, but a growing body of research…

3. 2d ago
   ConscienHealth indie

   More Than Weight in Knee Pain Relief with Retatrutide?

   Once again this week new data is telling us that the benefits of treating obesity can extend well beyond weight loss. Results from a pair of clinical trials with retatrutide offers an important example, showing impressive improvements in knee pain and physical function among people living with…

4. 1d ago
   The Medical Republic Australia indie

   Retatrutide transforms knee OA pain

   This content is for members only. Visit the site and log in/register to read.

5. 1d ago
   
   Healio indie

   Weight loss with retatrutide signals ‘new days’ in osteoarthritis

   ORLANDO — Weekly injections of the GLP-1 receptor agonist retatrutide improved knee osteoarthritis pain in addition to inducing weight loss, according to data presented at ACR Convergence. “It is no news to this audience that osteoarthritis is a major problem for patients and health systems,”…

6. 15h ago
   Medical Tribune (JP) Japan indie ja

   Triple agonist reduces pain in obese patients with knee osteoarthritis三重作動薬で膝OA合併肥満例の疼痛軽減

   Obesity is a risk factor for knee OA.肥満は、変形性膝関節症（膝OA）の発症と進行の危険因子である。管理においては減量が重要とされるが、既存の薬物療法の有効性は限られる。米・Northwestern University Feinberg School of MedicineのThomas J. Schnitzer氏らは、疼痛を伴う膝OAを合併する糖尿病のない成人肥満例を対象に、GIP／GLP-1／グルカゴン受容体三重作動薬retat...

7. 5h ago
   
   The Hindu Health India mainstream meta-analysis

   Experimental GLP-1 drug demonstrates pain relief in people with osteoarthritis during trials

   A pooled analysis of the studies found that about two-thirds of participants receiving the drug retatrutide experienced at least a 50% reduction in knee pain, compared with 38% of those receiving a placebo

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.